Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

USP Part D model formulary guidelines

Executive Summary

U.S. Pharmacopeia plans to release a draft version of its Medicare Part D model formulary guidelines 4.0 for the 2009 benefit year on Nov. 6, 2007. Comments on the draft will be accepted until Dec. 31, 2007, and a final version is scheduled to be forwarded to CMS by Feb. 4, 2008. USP's model guidelines expert committee is scheduled to consider the 4.0 version in a closed meeting scheduled for Oct. 1. Comments on the guidelines and requests for revision are accepted by USP throughout the year. The guidelines are used by CMS as a framework for reviewing formulary submissions by Part D plans...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS048732

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel